Affiliated with a Castle Connolly Top Hospital
Who is Dr. So, Surgeon in Stanford, CA?
Dr. Samuel So, MD is a Surgeon, who primarily practices in Stanford, CA with 1 additional practice location. He is board certified by the American Board of Radiologic Physics and American Board of Radiology. Dr. So graduated from University of Hong Kong, China and completed his residency at University of Minnesota. Dr. So is fluent in English and Chinese, and is currently seeing new patients. Dr. So’s practice accepts Medicare, UnitedHealthcare and other major insurance plans. To book an appointment or to confirm insurance options, please call Dr. So’s office.
What are Areas of Expertise for Dr. So?
Dr. Samuel So, MD is a highly-rated, board-certified Surgeon known for expertly diagnosing, treating, and managing a wide array of related conditions or procedures. Utilizing the latest medical advancements and evidence-based practices, Dr. So empowers patients to confidently navigate their health journey, specializing in Liver Tumors, Surgical Oncology, or comprehensive wellness support. Serving the Stanford/CA community, Dr. So is dedicated to enhancing lives through expert, patient-centered care.
Where did Dr. So go to medical school and complete their residency?
Fellowship: Univ. of Minnesota, Mpls., MN, Multi-organ Transplantation
Residency: University of Minnesota
Medical School: University of Hong Kong, China
Is Dr. So board certified in Surgeon?
Yes, Dr. Samuel So, MD is board certified by the American Board of Radiologic Physics , American Board of Radiology
What languages does Dr. So speak?
Dr. So and their clinical team can communicate with patients in the following languages:
Chinese
English
What conditions does Dr. So treat?
As a Surgeon, Dr. So diagnoses, treats, and manages a wide range of conditions. This condition information is derived from anonymized insurance claims and highlights the medical conditions most commonly treated by Dr. So. It provides insight into the doctor’s areas of experience and expertise based on real-world patient encounters from the past two years, updated quarterly.
Also known as:
- Chronic Hepatitis B
- Hepatitis B
- Long-term Hepatitis B
- Persistent Hepatitis B
- Hep B
ICD-10 Codes:
- B181: Chronic viral hepatitis B without delta-agent
Also known as:
- Liver Cancer
- Childhood Liver Cancer
- Hepatic Cancer
- Hepatocellular Carcinoma
ICD-10 Codes:
- C220: Liver cell carcinoma
Also known as:
- History of liver cancer
- Liver Cancer
- Past liver cancer
- Hepatic cancer survivor
- Previous liver malignancy
ICD-10 Codes:
- Z8505: Personal history of malignant neoplasm of liver
Which procedures does Dr. So perform as a Surgeon?
As a Surgeon, procedures performed by a Dr. Samuel So may include:
- Abdominal Wall Reconstruction
- Amputation
- Appendicitis / Appendectomy
- Brain Aneurysm Treatment
- Brain Surgery
- Brain Tumor Evaluation
- Central Line Placement
- Cerebral Shunt
For detailed information, please contact Dr. So's office.
Does Dr. So accept my insurance?
Dr. So accepts most major insurance plans. Important: Please call our office at before your appointment to verify that your specific plan and network are accepted.
What insurance plans does Dr. So accept in Stanford, CA?
Dr. So in Stanford, CA accepts plans from many carriers. While this list is updated regularly, it is not a guarantee of coverage.
Top Insurances
All Other Third Party
Blue Shield of California
CVS Health (formerly Aetna)
Express Scripts
Medicare
UnitedHealthcare
View All Insurances
Where is Dr. So's office located?
Recognitions
Publications
Suppressing N-Myc downstream regulated gene 1 reactivates senescence sigling
Carcinogenesis, 2014
Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives
WORLD JOURL OF GASTROENTEROLOGY, 2014
Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor
BioMed research intertiol, 2013
Education and counseling of pregnt patients with chronic hepatitis B
Asian Pacific jourl of cancer prevention, 2013
Assessment and comparison of magnetic noparticles as MRI contrast agents in a rodent model of human
CONTRAST MEDIA & MOLECULAR IMAGING, 2012
Low Levels of Knowledge
JOGNN-JOURL OF OBSTETRIC GYNECOLOGIC AND NEOTAL NURSING, 2012
A model program for hepatitis B vaccition and education of schoolchildren in rural Chi
INTERTIOL JOURL OF PUBLIC HEALTH, 2012
The CD47-sigl regulatory protein alpha
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2012
San Francisco Hep B Free: A Grassroots Community Coalition to Prevent Hepatitis B and Liver Cancer
JOURL OF COMMUNITY HEALTH, 2011
Soluble Frizzled-7 receptor inhibits Wnt sigling
MOLECULAR CANCER, 2011
Disparities in Liver Cancer Incidence by tivity, Acculturation
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010
Small molecule antagonists of Tcf4
INTERTIOL JOURL OF CANCER, 2010
Achieving health equity to elimite racial, ethnic
JOURL OF FAMILY PRACTICE, 2010
Hepatitis B and liver cancer knowledge and practices among healthcare and public health professiols
BMC PUBLIC HEALTH, 2010
Cost-Effectiveness of tionwide Hepatitis B Catch-up Vaccition Among Children and Adolescents in Chi
HEPATOLOGY, 2010
Blockade of Wnt-1 sigling leads to anti-tumor effects in hepatocellular carcinoma cells
MOLECULAR CANCER, 2009
The Jade Ribbon Campaign
JOURL OF IMMIGRANT AND MINORITY HEALTH, 2009
Frequent Ictivation of Axon Guidance Molecule RGMA in Human Colon Cancer Through Genetic
GASTROENTEROLOGY, 2009
Stopping a Silent Killer in the Underserved Asian and Pacific Islander Community
ASIAN PACIFIC JOURL OF CANCER PREVENTION, 2009
3 For Life: A Model Pilot Program to Prevent Hepatitis B Virus Infection and Liver Cancer in Asian
AMERICAN JOURL OF HEALTH PROMOTION, 2009
Elimiting the Threat of Chronic Hepatitis B in the Asian and Pacific Islander Community
ASIAN PACIFIC JOURL OF CANCER PREVENTION, 2009
Small interfering R targeting CDC25B inhibits liver tumor growth in vitro and in vivo
MOLECULAR CANCER, 2008
Phase H study of imatinib in unresectable hepatocellular carcinoma
AMERICAN JOURL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008
Attitudes toward Hepatitis B
ASIAN PACIFIC JOURL OF CANCER PREVENTION, 2008
Building partnerships with Traditiol Chinese Medicine Practitioners to incre
JOURL OF ALTERTIVE AND COMPLEMENTARY MEDICINE, 2007
Re: Ten largest racial and ethnic health disparities in the United States based on healthy people
AMERICAN JOURL OF EPIDEMIOLOGY, 2007
Cost-effectiveness of screening and vacciting Asian and pacific islander adults for hepatitis B
ANLS OF INTERL MEDICINE, 2007
Why we should routinely screen Asian American adults for hepatitis B
HEPATOLOGY, 2007
Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans
ASIAN PACIFIC JOURL OF CANCER PREVENTION, 2007
Comprehensive alysis of 19q12 amplicon in human gastric cancers
MODERN PATHOLOGY, 2006
Sprouty 2, an inhibitor of mitogen-activated protein kise sigling
CANCER RESEARCH, 2006
Topological and functiol discovery in a gene coexpression meta-network of gastric cancer
CANCER RESEARCH, 2006
Liver tumor gross margin identification
JOURL OF VASCULAR AND INTERVENTIOL RADIOLOGY, 2005
An integrated data alysis approach to characterize genes highly expressed
ONCOGENE, 2005
Phospholipase A2 group IIA expression
PROCEEDINGS OF THE TIOL ACADEMY OF SCIENCES OF THE UNITED STATES OF AM, 2002
Comprehensive alysis of the gene expression profiles in human gastric cancer cell lines
ONCOGENE, 2002
Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion.
Techniques in vascular and interventiol radiology, 2002
Identify metastasis-associated genes in hepatocellular carcinoma through clolity delineation for
CANCER RESEARCH, 2002
Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment
AMERICAN JOURL OF ROENTGENOLOGY, 2001
Genomic alysis of human hepatocellular carcinoma gene expression using cD microarrays.
Barry, C. T., MILLAN, M., Monge, H., Esquivel, C., BROWN, P., So, S., 1999
Minimal criteria for placement of adults on the liver transplant waiting list
Transplantation, 1998
Posttransplant lymphoproliferative disorders
TRANSPLANTATION, 1998
Minimal criteria for placement of adults on the liver transplant waiting list
Liver transplantation and surgery, 1997
Transjugular intrahepatic portosystemic shunt placement in a child complicated by perforated Roux
JOURL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1997
Superior outcomes in pediatric rel transplantation
Salvatierra, O., Alfrey, E., Tanney, D. C., Mak, R., Hammer, G. B., Kr, 1997
Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: A case report
JOURL OF PEDIATRIC SURGERY, 1997
Continuous venovenous hemofiltration with dialysis in combition with total hepatectomy
TRANSPLANTATION, 1996
FULMINT HEPATIC-FAILURE FOLLOWING VARICELLA
TRANSPLANTATION, 1995
ACUTE LIVER ALLOGRAFT-REJECTION IN THE RAT - AN ALYSIS OF THE IMMUNE RESPONSE
TRANSPLANTATION, 1995
EX-VIVO TECHNIQUE FOR RIGHT LOBECTOMY IN PEDIATRIC HEPATIC TRANSPLANTATION
JOURL OF THE AMERICAN COLLEGE OF SURGEONS, 1994
RESPIRATORY-DISTRESS FROM BENIGN LIVER
JOURL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1994
Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling
Carcinogenesis, 2014
Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives
WORLD JOURNAL OF GASTROENTEROLOGY, 2014
Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor
BioMed research international, 2013
Education and counseling of pregnant patients with chronic hepatitis B
Asian Pacific journal of cancer prevention, 2013
Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of
CONTRAST MEDIA & MOLECULAR IMAGING, 2012
Low Levels of Knowledge
JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 2012
A model program for hepatitis B vaccination and education of schoolchildren in rural China
INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 2012
The CD47-signal regulatory protein alpha
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2012
Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up
NEOPLASIA, 2011
San Francisco Hep B Free: A Grassroots Community Coalition to Prevent Hepatitis B and Liver Cancer
JOURNAL OF COMMUNITY HEALTH, 2011
In vivo MRSI of hyperpolarized [1-C-13]pyruvate metabolism in rat hepatocellular carcinoma
NMR IN BIOMEDICINE, 2011
Doing Good with Good OR: Supporting Cost-Effective Hepatitis B Interventions
INTERFACES, 2011
Comparative Profiling of Primary Colorectal Carcinomas
PLOS ONE, 2011
Soluble Frizzled-7 receptor inhibits Wnt signaling
MOLECULAR CANCER, 2011
Disparities in Liver Cancer Incidence by Nativity, Acculturation
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2010
Small molecule antagonists of Tcf4
INTERNATIONAL JOURNAL OF CANCER, 2010
Achieving health equity to eliminate racial, ethnic
JOURNAL OF FAMILY PRACTICE, 2010
Hepatitis B and liver cancer knowledge and practices among healthcare and public health
BMC PUBLIC HEALTH, 2010
Cost-Effectiveness of Nationwide Hepatitis B Catch-up Vaccination Among Children
HEPATOLOGY, 2010
Phase I/II Study of PHY906/Capecitabine in Advanced Hepatocellular Carcinoma
ANTICANCER RESEARCH, 2009
Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
MOLECULAR CANCER, 2009
The Jade Ribbon Campaign
JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 2009
Frequent Inactivation of Axon Guidance Molecule RGMA in Human Colon Cancer Through Genetic
GASTROENTEROLOGY, 2009
Stopping a Silent Killer in the Underserved Asian and Pacific Islander Community
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009
3 For Life: A Model Pilot Program to Prevent Hepatitis B Virus Infection and Liver Cancer in Asian
AMERICAN JOURNAL OF HEALTH PROMOTION, 2009
Eliminating the Threat of Chronic Hepatitis B in the Asian and Pacific Islander Community
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2009
N-Myc down-regulated gene 1 mediates proliferation, invasion
CANCER LETTERS, 2008
Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo
MOLECULAR CANCER, 2008
Phase H study of imatinib in unresectable hepatocellular carcinoma
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008
Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma.
Biomarker insights, 2008
Attitudes toward Hepatitis B
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2008
Building partnerships with Traditional Chinese Medicine Practitioners to incre
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 2007
Re: Ten largest racial and ethnic health disparities in the United States based on healthy people
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2007
Cost-effectiveness of screening and vaccinating Asian and pacific islander adults for hepatitis B
ANNALS OF INTERNAL MEDICINE, 2007
Why we should routinely screen Asian American adults for hepatitis B
HEPATOLOGY, 2007
The burden of liver cancer in Asians and Pacific Islanders in the greater San Francisco Bay Area
CANCER, 2007
Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma
MODERN PATHOLOGY, 2007
Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2007
Comprehensive analysis of 19q12 amplicon in human gastric cancers
MODERN PATHOLOGY, 2006
Gallium maltolate is a promising chemotherapeutic agent
ANTICANCER RESEARCH, 2006
Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling
CANCER RESEARCH, 2006
Topological and functional discovery in a gene coexpression meta-network of gastric cancer
CANCER RESEARCH, 2006
Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations
CARCINOGENESIS, 2005
Liver tumor gross margin identification
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2005
An integrated data analysis approach to characterize genes highly expressed
ONCOGENE, 2005
Mutations of PIK3CA in gastric adenocarcinoma
BMC CANCER, 2005
Transcript AA454543 is a novel prognostic marker
NEOPLASIA, 2005
Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma
CLINICAL CANCER RESEARCH, 2005
Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma
CANCER, 2005
Granulin-epithelin precursor overexpression promotes growth
CLINICAL CANCER RESEARCH, 2004
High prevalence of chronic hepatitis B
Chao, S., Le, P. V., Prapong, W., Su, J., So, S., 2004
Novel endothelial cell markers in hepatocellular carcinoma
MODERN PATHOLOGY, 2004
Expression profiling identifies chemokine
GASTROENTEROLOGY, 2004
One hundred percent patient and kidney allograft survival with simultaneous liver and kidney
TRANSPLANTATION, 2003
Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma
ONCOGENE, 2003
Variation in gene expression patterns in human gastric cancers
MOLECULAR BIOLOGY OF THE CELL, 2003
Phospholipase A2 group IIA expression
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES O, 2002
Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines
ONCOGENE, 2002
Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion.
Techniques in vascular and interventional radiology, 2002
Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for
CANCER RESEARCH, 2002
Gene expression patterns in human liver cancers
MOLECULAR BIOLOGY OF THE CELL, 2002
Epstein-Barr virus infection is associated with endothelial bcl
TRANSPLANTATION, 2002
Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment
AMERICAN JOURNAL OF ROENTGENOLOGY, 2001
Studies of Pediatric Liver Transplantation (SPLIT): Year 2000 outcomes
TRANSPLANTATION, 2001
Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis
Lai, K. M., MILLAN, M., Razavi, M., Keeffe, E. B., Prapong, W., Fisher, 2001
CMV and EBV-PTLD after liver transplantation
So, S., 2001
A 100% 2-year graft survival can be attained in high
Millan, M. T., Sarwal, M. M., Lemley, K. V., Yorgin, P., Orlandi, P., , 2000
Liver transplantation for hepatocellular carcinoma and the role of preoperative chemoembolization.
Millan, M. T., Lai, K. M., Keeffe, E. B., Fisher, G. A., Razavi, M. K., 2000
Intravenous ribavirin therapy for adenovirus pneumonia
PEDIATRIC PULMONOLOGY, 2000
Significance of detecting Epstein-Barr
Krieger, N. R., Martinez, O. M., Krams, S. M., Cox, K., So, S., Esquiv, 2000
CD81 gene expression is lost in hepatocellular carcinoma.
Drazan, K. E., Higgins, J., Fisher, G. A., Keefe, E., Barry, C. T., So, 1999
Resection versus transplantation for hepatocellular carcinoma
Esquivel, C. O., Keeffe, E. B., Garcia, G., Imperial, J. C., Millan, M, 1999
Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation
So, S. K., Esquivel, C. O., Imperial, J. C., Garcia, G., Monge, H., Ke, 1999
Major hepatic resection without blood transfusion: Experience with total vascular exclusion
So, S. K., Monge, H., Esquivel, C. O., 1999
Genomic analysis of human hepatocellular carcinoma gene expression using cDNA microarrays.
Barry, C. T., MILLAN, M., Monge, H., Esquivel, C., BROWN, P., So, S., 1999
Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
Pediatric transplantation, 1999
Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation
ARCHIVES OF SURGERY, 1999
Increased dosage requirement
TRANSPLANTATION PROCEEDINGS, 1998
Minimal criteria for placement of adults on the liver transplant waiting list
Transplantation, 1998
Posttransplant lymphoproliferative disorders
TRANSPLANTATION, 1998
Combined viral prophylactic and immunosuppressive strategy in liver transplantation
So, S. K., Esquivel, C. O., Imperial, J. C., Garcia, G., Keeffe, E. B., 1998
Liver transplantation in the first three months of life
TRANSPLANTATION, 1998
Allograft rejection after liver transplantation for autoimmune liver diseases
LIVER TRANSPLANTATION AND SURGERY, 1998
Indications for pediatric liver transplantation.
Pediatric transplantation, 1998
Current status of living-related liver transplantation.
Pediatric transplantation, 1998
Experience with the piggyback technique without caval occlusion
TRANSPLANTATION, 1998
Liver transplantation at Stanford University Medical Center.
Clinical transplants, 1998
Minimal criteria for placement of adults on the liver transplant waiting list
Liver transplantation and surgery, 1997
Transjugular intrahepatic portosystemic shunt placement in a child complicated by perforated Roux
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1997
Superior outcomes in pediatric renal transplantation
Salvatierra, O., Alfrey, E., Tanney, D. C., Mak, R., Hammer, G. B., Kr, 1997
Factors affecting survival after orthotopic liver transplantation in infants
TRANSPLANTATION, 1997
Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver
DIGESTIVE DISEASES AND SCIENCES, 1997
Orthotopic liver transplantation from non-heart-beating donor rats: Effect of flushing with cold
Tojimbara, T., Winston, W. N., So, S. K., Esquivel, C. O., 1997
Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: A case report
JOURNAL OF PEDIATRIC SURGERY, 1997
Liver transplantation in Asian patients with chronic hepatitis B
HEPATOLOGY, 1997
Primary liver transplantation without transfusion of red blood cells
Cacciarelli, T. V., Keeffe, E. B., Moore, D. H., BURNS, W., Chuljian, , 1996
Orthotopic liver transplantation for hepatocellular carcinoma - Factors affecting long
Ojogho, O. N., So, S. K., Keeffe, E. B., Berquist, W., Concepcion, W.,, 1996
Continuous venovenous hemofiltration with dialysis in combination with total hepatectomy
TRANSPLANTATION, 1996
Cyclosporine and tacrolimus both suppress activation of kupffer cells in vitro
Tojimbara, T., Bermudez, L. E., Egawa, H., Hayashi, M., So, S. K., Esq, 1996
Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation
TRANSPLANTATION, 1996
Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients
TRANSPLANTATION, 1996
Expression of cytokines and immune mediators during chronic liver allograft rejection
Hayashi, M., Martinez, O. M., GARCIAKENNEDY, R., So, S., Esquivel, C. , 1995
THE USE OF NON-HEART-BEATING CADAVER DONORS IN EXPERIMENTAL LIVER-TRANSPLANTATION
TRANSPLANTATION, 1995
FULMINANT HEPATIC-FAILURE FOLLOWING VARICELLA
TRANSPLANTATION, 1995
A REASSESSMENT OF ABO INCOMPATIBILITY IN PEDIATRIC LIVER-TRANSPLANTATION
TRANSPLANTATION, 1995
LIVER-TRANSPLANTATION IN A CHILD WITH SICKLE-CELL-ANEMIA
TRANSPLANTATION, 1995
EFFECTS OF PENTOXIFYLLINE PRETREATMENT ON KUPFFER CELLS IN RAT-LIVER TRANSPLANTATION
HEPATOLOGY, 1995
ISOLATED ALKALINE PHOSPHATEMIA FOLLOWING PEDIATRIC LIVER-TRANSPLANTATION IN THE FK506 ERA
TRANSPLANTATION, 1995
DIFFERENTIAL PATTERNS OF CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1
Lang, T., Krams, S. M., Villanueva, J. C., Cox, K., So, S., Martinez, , 1995
FK506 (TACROLIMUS) COMPARED WITH CYCLOSPORINE FOR PRIMARY IMMUNOSUPPRESSION AFTER PEDIATRIC LIVER
McDiarmid, S. V., Busuttil, R. W., Ascher, N. L., Burdick, J., DALESSA, 1995
AN INCREASED INCIDENCE OF EPSTEIN-BARR
Cox, K. L., LAWRENCEMIYASAKI, L. S., GARCIAKENNEDY, R., Lennette, E. T, 1995
IMPACT OF REDUCED-SIZE LIVER
Cacciarelli, T. V., So, S. K., Egawa, H., Cox, K., Esquivel, C. O., 1995
CHARACTERIZATION OF CYTOKINE EXPRESSION IN AN ANIMAL-MODEL OF ACUTE LIVER ALLOGRAFT-REJECTION
Egawa, H., Martinez, O. M., QUINN, M. B., So, S., Esquivel, C. O., Kra, 1995
FK-506 RESCUE THERAPY FOR HEPATIC ALLOGRAFT-REJECTION - EXPERIENCE WITH AN AGGRESSIVE APPROACH
CLINICAL TRANSPLANTATION, 1995
LONG-TERM NONRESPONSIVENESS TO A LIVER ALLOGRAFT MAY BE CYTOKINE-MEDIATED
Egawa, H., Martinez, O. M., QUINN, M. B., Villanueva, J. C., So, S., E, 1995
DISTINCT PATTERNS OF TH2 CYTOKINE PRODUCTION DURING IMMUNE ACTIVATION IN PEDIATRIC LIVER ALLOGRAFT
Lang, T., Krams, S. M., Villanueva, J. C., Cox, K., So, S., Esquivel, , 1995
MOLECULAR MARKERS OF EPSTEIN-BARR-VIRUS INFECTION IN THE CIRCULATION OF TRANSPLANT RECIPIENTS
Martinez, O. M., Villanueva, J. C., LAWRENCEMIYASAKI, L., QUINN, M. B., 1995
CIRCULATING INTERCELLULAR-ADHESION MOLECULE
Lang, T., Krams, S. M., Villanueva, J. C., So, S. K., Berquist, W. E.,, 1995
ACUTE LIVER ALLOGRAFT-REJECTION IN THE RAT - AN ANALYSIS OF THE IMMUNE RESPONSE
TRANSPLANTATION, 1995
EX-VIVO TECHNIQUE FOR RIGHT LOBECTOMY IN PEDIATRIC HEPATIC TRANSPLANTATION
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1994
NEUROLOGICAL COMPLICATIONS OF LIVER-TRANSPLANTATION IN ADULT VERSUS PEDIATRIC-PATIENTS
TRANSPLANTATION, 1994
RESPIRATORY-DISTRESS FROM BENIGN LIVER
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1994
FK506 CONVERSION THERAPY IN PEDIATRIC LIVER-TRANSPLANTATION
TRANSPLANTATION, 1994
PREVENTION OF REJECTION AND GRAFT LOSS WITH AN AGGRESSIVE QUADRUPLE IMMUNOSUPPRESSIVE THERAPY
Conley, S. B., ALUZRI, A., So, S., Salvatierra, O., 1994
INDUCTION IMMUNOSUPPRESSION WITH ANTILYMPHOCYTE GLOBULIN OR OKT3 IN CADAVER KIDNEY-TRANSPLANTATION
TRANSPLANTATION
What is Dr. So's NPI number?An National Provider Identifier (NPI) is a unique ID number that identifies doctors and healthcare providers nationwide.
Dr. So's National Provider Identifier (NPI) number is 1982730065.
What common questions do patients ask about Dr. So?
Here are answers to patients Frequently Asked Questions (FAQ’s) about Dr. So
What is Dr. Samuel So's specialty?
Dr. So is a Surgeon near Stanford, CA. General surgeons are experts in diagnosing and managing surgical conditions which includes preoperative, operative, and postoperative care, as well as addressing complications. Their expertise include the areas such as the alimentary tract, breast, abdomen, skin and soft tissue, endocrine system, head and neck, pediatric surgery, surgical critical care, surgical oncology, trauma, burns, and vascular surgery. General surgeons increasingly utilize minimally invasive and endoscopic techniques to provide proper care. In addition to this, many general surgeons have expertise in transplantation, plastic, and cardiothoracic surgery. Contact Dr. So to book an appointment today.
Is this Dr. Samuel So affiliated with a ranked Castle Connolly Top Hospital?
Yes, Dr. So is affiliated with Stanford Health Care - Stanford Hospital which is a Castle Connolly Top Hospital. Castle Connolly Top Hospitals are healthcare institutions recognized for their excellence in specific medical procedures and overall patient care. They are identified through a rigorous peer nomination process, evaluating factors like patient outcomes, quality of care, and expertise. The list recognizes hospitals that excel in 20 or more specific medical procedures, representing the top 25% nationwide. Castle Connolly Top Hospitals
Where can I learn more about Surgeon?
Explore Surgeon with insights from trusted medical experts on EverydayHealth.com, where you'll find the most relevant content and helpful condition guides for up-to date information about symptoms, causes, diagnosis, treatment and more. See all our health guides to find trusted information on medical conditions from our experts at Everyday Health.
Is Samuel So accepting new patients in Stanford, CA?
Yes, Dr. Samuel So is accepting new patients at this time.
Does Dr. Samuel So offer online booking?
Please contact Dr. So's office for information about online booking, telehealth, or to schedule an appointment.
How can I make an appointment with Samuel So?
Please contact Dr. So's office for information regarding telehealth appointment availability or for scheduling assistance.
Which board certifications does Dr. Samuel So have?
Dr. Samuel So is certified by the American Board of Radiologic Physics and American Board of Radiology.
Other Surgeon Near Stanford, CA
Surgeon
Accepting patientsAccepting patientsUrologist
Accepting patients